This company has been marked as potentially delisted and may not be actively trading. Lionheart Acquisition Co. II (LCAP) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LCAP vs. ACHC, ARQT, ANIP, HRMY, IDYA, AORT, BEAM, RXRX, PGNY, and QDELShould you be buying Lionheart Acquisition Co. II stock or one of its competitors? The main competitors of Lionheart Acquisition Co. II include Acadia Healthcare (ACHC), Arcutis Biotherapeutics (ARQT), ANI Pharmaceuticals (ANIP), Harmony Biosciences (HRMY), IDEAYA Biosciences (IDYA), Artivion (AORT), Beam Therapeutics (BEAM), Recursion Pharmaceuticals (RXRX), Progyny (PGNY), and QuidelOrtho (QDEL). These companies are all part of the "medical" sector. Lionheart Acquisition Co. II vs. Its Competitors Acadia Healthcare Arcutis Biotherapeutics ANI Pharmaceuticals Harmony Biosciences IDEAYA Biosciences Artivion Beam Therapeutics Recursion Pharmaceuticals Progyny QuidelOrtho Lionheart Acquisition Co. II (NASDAQ:LCAP) and Acadia Healthcare (NASDAQ:ACHC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Which has more risk and volatility, LCAP or ACHC? Lionheart Acquisition Co. II has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Which has stronger earnings & valuation, LCAP or ACHC? Acadia Healthcare has higher revenue and earnings than Lionheart Acquisition Co. II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLionheart Acquisition Co. IIN/AN/A$3.21MN/AN/AAcadia Healthcare$3.15B0.64$255.61M$1.5114.39 Does the media prefer LCAP or ACHC? In the previous week, Acadia Healthcare had 22 more articles in the media than Lionheart Acquisition Co. II. MarketBeat recorded 22 mentions for Acadia Healthcare and 0 mentions for Lionheart Acquisition Co. II. Acadia Healthcare's average media sentiment score of 0.64 beat Lionheart Acquisition Co. II's score of 0.00 indicating that Acadia Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Lionheart Acquisition Co. II Neutral Acadia Healthcare Positive Do analysts rate LCAP or ACHC? Acadia Healthcare has a consensus target price of $39.00, suggesting a potential upside of 79.48%. Given Acadia Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Acadia Healthcare is more favorable than Lionheart Acquisition Co. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lionheart Acquisition Co. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Acadia Healthcare 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62 Is LCAP or ACHC more profitable? Acadia Healthcare has a net margin of 4.31% compared to Lionheart Acquisition Co. II's net margin of 0.00%. Acadia Healthcare's return on equity of 8.34% beat Lionheart Acquisition Co. II's return on equity.Company Net Margins Return on Equity Return on Assets Lionheart Acquisition Co. IIN/A -44.30% 1.39% Acadia Healthcare 4.31%8.34%4.20% SummaryAcadia Healthcare beats Lionheart Acquisition Co. II on 11 of the 11 factors compared between the two stocks. Get Lionheart Acquisition Co. II News Delivered to You Automatically Sign up to receive the latest news and ratings for LCAP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LCAP vs. The Competition Export to ExcelMetricLionheart Acquisition Co. IIBusiness Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$527.62M$146.12M$5.85B$10.14BDividend YieldN/AN/A5.68%4.60%P/E RatioN/A112.9575.3425.98Price / SalesN/A14.44514.54181.13Price / Cash20.6411.7037.5660.44Price / Book-10.032.8012.156.29Net Income$3.21M$1.30M$3.29B$271.07M Lionheart Acquisition Co. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LCAPLionheart Acquisition Co. IIN/A$28.59-0.1%N/A+16,928.3%$527.62MN/A0.003ACHCAcadia Healthcare4.4958 of 5 stars$23.30+3.4%$39.00+67.4%-71.9%$2.08B$3.15B15.4325,500News CoverageAnalyst DowngradeARQTArcutis Biotherapeutics2.4296 of 5 stars$17.93+3.5%$19.80+10.4%+64.4%$2.08B$263.47M-23.91150Insider TradeANIPANI Pharmaceuticals4.0326 of 5 stars$98.46+3.4%$88.25-10.4%+74.0%$2.07B$614.38M-127.87600Positive NewsHRMYHarmony Biosciences4.6079 of 5 stars$34.00-5.1%$51.00+50.0%-14.2%$2.06B$772.53M10.97200Positive NewsHigh Trading VolumeIDYAIDEAYA Biosciences3.9802 of 5 stars$24.74+5.8%$42.75+72.8%-31.8%$2.05B$7M-6.5380Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading VolumeAORTArtivion2.781 of 5 stars$42.52-2.1%$40.63-4.4%+64.4%$2.05B$388.54M-101.231,600Positive NewsBEAMBeam Therapeutics2.873 of 5 stars$20.36+2.1%$48.45+138.0%-15.6%$2.02B$60.27M-4.52510RXRXRecursion Pharmaceuticals2.154 of 5 stars$4.70+1.7%$7.25+54.3%-25.7%$2.01B$58.84M-2.64400News CoverageAnalyst ForecastOptions VolumeGap UpPGNYProgyny3.761 of 5 stars$22.97+0.5%$25.30+10.1%-3.2%$1.96B$1.24B38.93310Positive NewsQDELQuidelOrtho4.3105 of 5 stars$28.56+0.3%$39.20+37.3%-36.2%$1.93B$2.78B-4.376,600Positive News Related Companies and Tools Related Companies ACHC Alternatives ARQT Alternatives ANIP Alternatives HRMY Alternatives IDYA Alternatives AORT Alternatives BEAM Alternatives RXRX Alternatives PGNY Alternatives QDEL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LCAP) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lionheart Acquisition Co. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Lionheart Acquisition Co. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
